CMR Surgical, a surgical robotics company, has received FDA de novo marketing clearance for its Versius surgical robotic system. The system enables soft tissue minimal access surgery for cholecystectomy in adults over 22 years old.
Versius, which obtained CE mark approval in 2019, is designed for robotic minimal access surgery, offering features such as 3D HD vision, easy-to-adopt instrument control, and ergonomic working positions. CMR Surgical plans to partner with select hospitals as part of its strategy to enter the US market.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.